Serum betatrophin levels are significantly increased in obese patients compared to lean patients regardless to the presence of PCOS


Keyif B., Goksever Celik H., KARAMUSTAFAOĞLU BALCI B., Mehves Celebi M., Ozaltin S., TAKMAZ Ö., ...More

GYNECOLOGICAL ENDOCRINOLOGY, vol.36, no.8, pp.678-681, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 8
  • Publication Date: 2020
  • Doi Number: 10.1080/09513590.2020.1725964
  • Journal Name: GYNECOLOGICAL ENDOCRINOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
  • Page Numbers: pp.678-681
  • Keywords: Betatrophin, obesity, PCOS, sex hormone–binding globulin, total testosterone
  • Istanbul University Affiliated: Yes

Abstract

Betatrophin, which regulates glucose metabolism, is primarily expressed in liver and fat tissue. We aimed to investigate betatrophin levels in patients with polycystic ovary syndrome (PCOS) that is the most common endocrine pathology in women of reproductive age. A total of 69 women were included in this prospective study: 35 patients with PCOS (18 obese and 17 lean) and 34 healthy controls (17 obese and 17 lean). Patients who met the criteria were compared regarding betatrophin levels and other hormonal values. Serum betatrophin level did not differ between obese PCOS patients and obese controls, and lean PCOS patients and lean controls; while significantly increased in obese PCOS patients and controls compared to lean PCOS patients and controls. Total testosterone and androstenedione were significantly higher in patients with PCOS than in controls both in the obese and lean groups, while sex hormone-binding globulin was significantly lower in patients with PCOS than in controls both in the obese and lean groups. However, remaining hormone values were similar between groups. Betatrophin level was significantly increased in obese patients compared to lean patients independent to the presence of PCOS.